Marchi, Pedro De; Melendez, Matias E; Laus, Ana C; Kuhlmann, Pamela A; Carvalho, Ana Carolina de; Arantes, Lidia Maria R. B; Evangelista, Adriane F; Andrade, Edilene S; Castro Junior, Gilberto de Castro 
; Reis, Rui M
Source: Oral oncology. Unidade: FM
Subjects: NEOPLASIAS DE CABEÇA E PESCOÇO, POLIMORFISMO, CARCINOMA DE CÉLULAS ESCAMOSAS, SEQUENCIAMENTO GENÉTICO, QUIMIOTERAPIA, ANTINEOPLÁSICOS, PROTEÍNAS DE TRANSPORTE, GENÓTIPOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARCHI, Pedro De et al. The role of single-nucleotide polymorphism (SNPs) in toxicity of induction chemotherapy based on cisplatin and paclitaxel in patients with advanced head and neck cancer. Oral oncology, v. 98, p. 48-52, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.oraloncology.2019.09.013. Acesso em: 06 nov. 2024.APA
Marchi, P. D., Melendez, M. E., Laus, A. C., Kuhlmann, P. A., Carvalho, A. C. de, Arantes, L. M. R. B., et al. (2019). The role of single-nucleotide polymorphism (SNPs) in toxicity of induction chemotherapy based on cisplatin and paclitaxel in patients with advanced head and neck cancer. Oral oncology, 98, 48-52. doi:10.1016/j.oraloncology.2019.09.013NLM
Marchi PD, Melendez ME, Laus AC, Kuhlmann PA, Carvalho AC de, Arantes LMRB, Evangelista AF, Andrade ES, Castro Junior G de C, Reis RM. The role of single-nucleotide polymorphism (SNPs) in toxicity of induction chemotherapy based on cisplatin and paclitaxel in patients with advanced head and neck cancer [Internet]. Oral oncology. 2019 ; 98 48-52.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.oraloncology.2019.09.013Vancouver
Marchi PD, Melendez ME, Laus AC, Kuhlmann PA, Carvalho AC de, Arantes LMRB, Evangelista AF, Andrade ES, Castro Junior G de C, Reis RM. The role of single-nucleotide polymorphism (SNPs) in toxicity of induction chemotherapy based on cisplatin and paclitaxel in patients with advanced head and neck cancer [Internet]. Oral oncology. 2019 ; 98 48-52.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.oraloncology.2019.09.013
